Drug Shortage Report for SODIUM CHLORIDE INJECTION, USP
| Report ID | 165704 |
| Drug Identification Number | 02139510 |
| Brand name | SODIUM CHLORIDE INJECTION, USP |
| Common or Proper name | SODIUM CHLORIDE INJECTION, USP |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | SODIUM CHLORIDE |
| Strength(s) | 234MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 200 mL |
| ATC code | B05XA |
| ATC description | I.V. SOLUTION ADDITIVES |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2022-08-01 |
| Estimated end date | 2022-08-21 |
| Actual end date | 2022-08-15 |
| Shortage status | Resolved |
| Updated date | 2022-08-21 |
| Company comments | Fresenius Kabi Canada regrets to advise that due to shipping delays, we will be encountering a supply interruption on our Sodium Chloride Injection, USP 4mEq/mL Maxivial® 200 mL effective August 1, 2022 until August 21, 2022. Once available, this product will remain on allocation. Contract customers will be allocated 100% of historical monthly demand. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2022-08-21 | French | Compare |
| v4 | 2022-08-21 | English | Compare |
| v3 | 2022-08-02 | English | Compare |
| v2 | 2022-07-29 | French | Compare |
| v1 | 2022-07-29 | English | Compare |
Showing 1 to 5 of 5